Fig. 6 S3-activated AMPK induces glucose uptake through CaMKKb-dependent signaling. a L6 myotubes were pretreated for 48 h with two siRNAs targeted against LKB1 or a non-related siRNA (mock) (each siRNA at 100 nM). Cells were then incubated with S3, 10 lM V 2 O 5 , or vehicle. Glucose uptake was measured in the L6 myotubes as described in the ''Materials and methods.'' Data were compiled from four independent experiments and are expressed as means ± SE. **P \ 0.01, compared to the DDW control. b, c Cells were preincubated with S3-mediated media for 1 week and then treated with STO-609 (10 lg/ml), or pretreated with 10 lg/ml of CaMKK inhibitor (STO-609) for 30 min and then treated with 10 lM V 2 O 5 for 2 h. Cell lysates were prepared and subjected to immunoblot analysis using specific antibodies against p-AMPK, p-ACC, and btubulin. Glucose uptake was measured in the L6 myotubes as described in the ''Materials and methods.'' Data were compiled from four independent experiments and are expressed as means ± SE. *P \ 0.05, **P \ 0.01 or ***P \ 0.001 compared to the DDW control
